Baotou Dongbao Bio-Tech Co Ltd (300239) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.19 Million ≈ $1.20 Million USD) by net assets (CN¥1.69 Billion ≈ $247.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Baotou Dongbao Bio-Tech Co Ltd to measure how much of total assets are equity-financed.
Baotou Dongbao Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300239 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Baotou Dongbao Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Issta Lines Ltd
TA:ISTA
|
0.034x |
|
CN EVERBRIGHT WATER HD 1
F:BIU2
|
N/A |
|
Benitec Biopharma Ltd ADR
NASDAQ:BNTC
|
-0.020x |
|
Attica Holdings S.A.
AT:ATTICA
|
0.023x |
|
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
|
0.027x |
|
Panin Financial Tbk
JK:PNLF
|
0.014x |
|
Fujian Minfa Aluminium Co Ltd
SHE:002578
|
-0.035x |
|
China Chippacking Technology Co. Ltd. A
SHG:688216
|
N/A |
Annual Cash Flow Conversion Efficiency for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Baotou Dongbao Bio-Tech Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.72 Billion ≈ $252.16 Million |
CN¥105.92 Million ≈ $15.50 Million |
0.061x | +54.67% |
| 2024-12-31 | CN¥1.74 Billion ≈ $254.53 Million |
CN¥69.13 Million ≈ $10.12 Million |
0.040x | -62.26% |
| 2023-12-31 | CN¥1.89 Billion ≈ $277.03 Million |
CN¥199.39 Million ≈ $29.18 Million |
0.105x | -5.32% |
| 2022-12-31 | CN¥1.76 Billion ≈ $256.94 Million |
CN¥195.32 Million ≈ $28.58 Million |
0.111x | +246.38% |
| 2021-12-31 | CN¥1.60 Billion ≈ $234.67 Million |
CN¥51.50 Million ≈ $7.54 Million |
0.032x | -49.22% |
| 2020-12-31 | CN¥998.18 Million ≈ $146.07 Million |
CN¥63.13 Million ≈ $9.24 Million |
0.063x | +250.67% |
| 2019-12-31 | CN¥991.86 Million ≈ $145.14 Million |
CN¥-41.63 Million ≈ $-6.09 Million |
-0.042x | -152.53% |
| 2018-12-31 | CN¥750.88 Million ≈ $109.88 Million |
CN¥60.00 Million ≈ $8.78 Million |
0.080x | +1970.83% |
| 2017-12-31 | CN¥729.75 Million ≈ $106.79 Million |
CN¥-3.12 Million ≈ $-456.11K |
-0.004x | -107.57% |
| 2016-12-31 | CN¥718.86 Million ≈ $105.19 Million |
CN¥40.54 Million ≈ $5.93 Million |
0.056x | -12.57% |
| 2015-12-31 | CN¥706.55 Million ≈ $103.39 Million |
CN¥45.57 Million ≈ $6.67 Million |
0.065x | +279.51% |
| 2014-12-31 | CN¥340.56 Million ≈ $49.83 Million |
CN¥-12.24 Million ≈ $-1.79 Million |
-0.036x | -239.04% |
| 2013-12-31 | CN¥351.47 Million ≈ $51.43 Million |
CN¥9.08 Million ≈ $1.33 Million |
0.026x | +53.46% |
| 2012-12-31 | CN¥324.03 Million ≈ $47.42 Million |
CN¥5.46 Million ≈ $798.48K |
0.017x | -79.42% |
| 2011-12-31 | CN¥295.99 Million ≈ $43.31 Million |
CN¥24.22 Million ≈ $3.54 Million |
0.082x | -15.71% |
| 2010-12-31 | CN¥122.44 Million ≈ $17.92 Million |
CN¥11.88 Million ≈ $1.74 Million |
0.097x | -29.35% |
| 2009-12-31 | CN¥100.65 Million ≈ $14.73 Million |
CN¥13.83 Million ≈ $2.02 Million |
0.137x | +422.49% |
| 2008-12-31 | CN¥97.87 Million ≈ $14.32 Million |
CN¥-4.17 Million ≈ $-610.07K |
-0.043x | -- |
About Baotou Dongbao Bio-Tech Co Ltd
Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen and their derivative products in the People's Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private la… Read more